THIENYL-CONTAINING GLYCOPYRANOSYL DERIVATIVES AS ANTIDIABETICS

Disclosed is a compound of formula (I) wherein RA is a halogen atom, or a C1-C6 alkyl group; and Ring c is a phenyl group substituted by 1-3 substituents selected from the group consisting of a halogen atom, a cyano group, a C1-C6 alkyl group, a halo- C1-C6 alkyl group, a C1-C6 alkoxy group, a halo-...

Full description

Saved in:
Bibliographic Details
Main Authors LIM, HENG-KEANG, VILLANI, FRANK J, BAUMANN, CHRISTIAN ANDREW, SCOTT, LORRAINE, COOK, KEVIN L
Format Patent
LanguageEnglish
Published 25.11.2011
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Disclosed is a compound of formula (I) wherein RA is a halogen atom, or a C1-C6 alkyl group; and Ring c is a phenyl group substituted by 1-3 substituents selected from the group consisting of a halogen atom, a cyano group, a C1-C6 alkyl group, a halo- C1-C6 alkyl group, a C1-C6 alkoxy group, a halo- C1-C6 alkoxy group, a methylenedioxy group, an ethyleneoxy group, a mono-or di- C1-C6 alkylamino group, a carbamoyl group, and a mono-or di- C1-C6 alkylcarbamoyl group; or a heterocyclyl group substituted by 1-3 substituents selected from the group consisting of a halogen atom, a cyano group, a C1-C6 alkyl group, a halo- C1-C6 alkyl group, a C1-C6 alkoxy group, a halo- C1-C6 alkoxy group, a mono-or di- C1-C6 alkylamino group, a carbamoyl group, and a mono or di- C1-C6 alkylcarbamoyl group; or a pharmaceutically acceptable salt thereof.
Bibliography:Application Number: NZ20070577391